期刊文献+

慢性乙型肝炎患者血清中sICOS和sPD-1升高及意义 被引量:5

Expression and significance of s ICOS/s PD-1 in the serum of patients with chronic hepatitis B
下载PDF
导出
摘要 目的检测慢性乙型肝炎(CHB)患者血清中可溶性可诱导共刺激分子(s ICOS)和可溶性程序性死亡蛋白1(s PD-1)的蛋白水平,并初步探讨其意义。方法收集80例CHB患者和30例健康对照者外周血单个核细胞(PBMCs)和血液上清。根据HBs Ag和HBe Ag测定值,将CHB患者分为HBe Ag(-)和HBe Ag(+)两组;并将HBe Ag(+)组分为免疫耐受期和免疫清除期。用ELISA法检测以上研究对象外周血上清中s ICOS和s PD-1蛋白浓度。用实时荧光定量PCR检测PBMCs中ICOS、PD-1和PD-1Δex3的表达。结果与对照相比,s ICOS在CHB患者中均增高(P<0.05);而s PD-1仅在HBe Ag(+)组显著增高(P<0.01),其中免疫清除期比免疫耐受期患者增高更明显(P<0.05)。CHB患者的s PD-1与AST呈正相关(P<0.01);且HBe Ag(+)组的s PD-1与ALT呈正相关(P<0.01);CHB患者的s ICOS与HBV-DNA呈弱的负相关性(P<0.05)。活化前,两组CHB患者的ICOS mRNA表达水平均降低(P<0.05)。结论 s ICOS和s PD-1在CHB患者的血清中均异常增高,提示s ICOS和s PD-1可能参与了CHB的发生发展。 Objective To detect the level of soluble inducible co-stimulator molecule (sICOS) and soluble programmed death protein 1 (sPD-1) in peripheral blood supematant in patients with chronic hepatitis B and then discuss its significance with other index.Methods Eighty patients with CHB and thirty healthy persons were enrolled in our study.the peripheral blood supernatants were collected and isolated the peripheral blood mononuclear cells (PBMCs) in CHB patients.According to the clinical HBsAg and HBeAg results,the CHB patients can be divided into the HBeAg(-) group and the HBeAg (+) group,simultaneously,the HBeAg (+) group was divided into two parts:the immune tolerance group and immune clearance group.The sICOS and sPD-1 expression in the peripheral blood was measured by ELISA.The mRNA expression of ICOS,PD-1 and PD-1Aex3 in PBMCs of patients with CHB were detected by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR).Results sICOS level was significantly higher in CHB patients compairing the healthy controls (P <0.05);.as same as the HBeAg(+) persons,sPD-1 was increased(P <0.01),in which the sPD-1 level was increased more obviously in patients who were in immune clearance phase than those in immune tolerance phase (P <0.05).sPD-1 was positively correlated with the AST levels in CHB patients(P <0.01);The sPD-1 was only correlated with the ALT levels in the HBeAg(+) patients (P <0.01).But there is no correlation between sICOS level and ALT or AST levels.A weakly negative correlation between HBV-DNA and sICOS levels was observed (P < 0.05).Whereas the sICOS did not correlate with HBeAg levels.Compared with the healthy controls,before the activation and stimulation,the ICOS mRNA expressions were decreased in two CHB groups (P < 0.05).Conclusions The sICOS and sPD-1 levels are significantly higher in the serum of patients with CHB and they may be able to participate in the development of CHB.
出处 《基础医学与临床》 CSCD 2015年第7期916-920,共5页 Basic and Clinical Medicine
基金 国际科技合作专项项目(2015DFA30420)
关键词 ICOS PD-1 慢性乙型肝炎 ICOS PD-1 chronic hepatis B
  • 相关文献

参考文献10

  • 1Coyle AJ, Gutierrez-Ramos JC. The role of ICOS and other eostimulatory molecules in allergy and asthma[J]. Springer Semin Immun, 2004, 25: 349-359.
  • 2Cao J, Zhang LP, Huang SF, et al. Aberrant production of soluble co-stimulatory molecules CTLA-4 and CD28 in pa- tients with chronic hepatitis B [ J ]. Microbial Pathogenesis, 2011,51: 262-267.
  • 3Gao Q, Wang XY, Qiu sJ, et al. Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcino- ma[J]. Clin Cancer Res, 2009, 15: 971-979.
  • 4Nielsen C, Ohm-Laursen L, Barington T, et al. Alternative splice variants of the human PD- 1 gene [ J ]. Cell Immunol, 2005, 235 : 109-116.
  • 5Yanaba K, Asano Y, Noda S, et al. Increased production of soluble inducible costimulator in patients with diffuse cu-taneous systemic sclerosis[ J]. Arch Dermatol Res, 2013, 305 : 17-23.
  • 6邱惠,张慧,冯作化,张桂梅.分泌型重组多肽sPD-1-CellⅠ(P/C-1)调节免疫细胞功能活性及抗肿瘤效应的研究[J].中华微生物学和免疫学杂志,2006,26(12):1053-1058. 被引量:1
  • 7张云志.ICOS-B7h研究进展[J].中国免疫学杂志,2004,20(7):507-509. 被引量:2
  • 8周俊英,魏峰,李俊卿.程序性死亡受体-1与丙型病毒性肝炎[J].基础医学与临床,2010,30(11):1218-1221. 被引量:1
  • 9韩凌斐,张桂梅,刘毅,李东,邱惠,耿辉,肖晗,吴丰华,冯作化.sPD-1和4-1BBL体内联合表达对小鼠实验性肝癌的治疗作用[J].中华微生物学和免疫学杂志,2006,26(9):831-835. 被引量:3
  • 10Her M, Kim D, Oh M, et al. Increased expression of sol- uble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus [ J ]. Lupus, 2009, 18: 501-507.

二级参考文献54

  • 1贺宇飞,张桂梅,王小红,张慧,袁野,李东,冯作化.PD-1胞外段cDNA在真核细胞的表达与其功能鉴定[J].生物工程学报,2004,20(5):699-703. 被引量:9
  • 2邱惠,张桂梅,张慧,袁野,李东,冯作化.4-1BBL联合Hsp70-肿瘤抗原肽抑制小鼠黑色素瘤肺转移[J].癌症,2005,24(7):781-786. 被引量:4
  • 3Rassa JC, Meyers JL, Zhang Y, et al. Murine retroviruses activate B cells via interaction with TolMike receptor 4 [J]. Proc Natl Acad Sci USA, 2002, 99:2281-2286.
  • 4Jurk M, Heil F, Vollmer J, et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 [J]. Nat Immunol, 2002, 3:196-200.
  • 5Carter L, Fouser LA, Jussif J, et al. PD-1 : PD-L inhibitory pathway affects both CD4^+ and CD8^+ T cells and is overcome by IL-2 [ J]. Eur J Immunol, 2002, 32:634 - 643.
  • 6Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8^+ T cells during chronic viral infection [ J ]. Nature, 2006, 439 : 682 - 687.
  • 7Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression [ J ]. Nature, 2006, 433:350 - 354.
  • 8Urbani S, Amadei B, Tola D, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8^+ exhaustion [ J ]. J Virol, 2006, 80 : 11398 - 11403.
  • 9Nakamoto N, Cho H, Shaked A, et al. Synergistic reversal of intrahepatic HCV-specific CD8^+T cell exhaustion by combined PD-1/CTLA-4 blockade [ J ]. P LoS Pathog, 2009, 5:e10003.
  • 10Kasprowicz V, Schulze Zur Wiesch J, Kuntzen T, et al. High level of PD-1 expression on hepatitis C virus (HCV) -specific CD8^+ and CD4^+ T cells during acute HCV infection, irrespective of clinical outcome [ J ]. J Virol, 2008, 82:3154-3160.

共引文献3

同被引文献43

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部